Anna Rivkin - 22 Jan 2025 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Business Officer
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Anna Rivkin
Issuer symbol
FHTX
Transactions as of
22 Jan 2025
Net transactions value
+$218,500
Form type
4
Filing time
24 Jan 2025, 16:11:43 UTC
Previous filing
04 Sep 2024
Next filing
02 Feb 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Option (right to buy) Award $218,500 +50,000 $4.37 50,000 22 Jan 2025 Common Stock 50,000 $4.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.